Subclinical hypothyroïdism Clinical Trials
2 recruiting trials for Subclinical hypothyroïdism. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Subclinical hypothyroïdism clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Zhujiang Hospital (1), Cairo University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is no intervention (other, 1 trial), followed by physical exercise program, usual care.
Track Subclinical hypothyroïdism trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
The human gut microbiome has been associated with many health factors but variability between studies limits the exploration of effects between them. This study aims to...
Efficay of Physical Activity Program in PCOS Females With Fatty Pancrease and Thyroid Hypofunction
females of polycystic ovary syndromes may complain fatty pancreaetic disorder and thyroid hypofunctions (subclinical hypothyroidism)
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Subclinical hypothyroïdism, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Subclinical hypothyroïdism, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Subclinical hypothyroïdism, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.